Topic: GlaxoSmithKline plc
Summary: GSK and Genmab announce the initiation of a Phase III study of ofatumumab in rituximab refractory patients with indolent B-cell...
OK class, today's lesson is on the pitfalls of similar stock performance. It's tempting to think that all companies in a certain industry behave...
Simon Dingemans is joining GlaxoSmithKline as chief financial officer. Photograph: Warren Little/Getty Images . We understood when Jon Symonds quit...
European Medicines Agency probes safety of diabetes drug. . * Will finalise review at meeting on Sept. 20-23. The European Medicines Agency said it...
Drugmaker GlaxoSmithKline insisted there would be no change to its cautious stance on deal-making, after announcing it had hired one of Europe's ...
GlaxoSmithKline (NYSE: GSK) announced on Wednesday that it has hired former Goldman Sachs Group Inc. (NYSE: GS) investment banker Simon Dingemans...
By James Cone . . GlaxoSmithKline Plc said Julian Heslop is to retire as chief financial officer and executive director at the end of March 2011...
GlaxoSmithKline, the British pharmaceutical giant, said that Simon Dingemans, head of the European M. A. business at Goldman Sachs, would become...
Bank of America Corp (NYSE: BAC)'s Merrill Lynch division analysts upgraded shares of Biovail Corp (NYSE: BF) from $27.00 to $32.00 in a research...
This week a BMJ investigation suggests that the diabetes drug rosiglitazone should never have been licensed and should now be withdrawn...
Photo Gallery
Video Gallery
-
News Update: New Study Shows GlaxoSmithKline ...
A study in the Journal of the American Medical Association ...2010-06-28 -
GlaxoSmithKline Plc (GSK)
Everyone is looking for a nice save haven in these ...2008-02-13 -
News Update: GlaxoSmithKline to Pay Over ...
GlaxoSmithKline Plc (GSK) will pay pay more than $1 billion ...2010-07-20
